Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... tumours. They tested the drug on its own and alongside the standard chemotherapy agent cisplatin, which is frequently used to treat patients with the disease. In the first mouse model, ...
2009 NOV 23 ... 55 years or older were compared with patients younger than 55 years who received weekly cisplatin during pelvic radiation for differences in chemoradiation administration, toxicity, and ...
2009 NOV 26 ... to investigate the protective role of royal jelly (RJ) and green tea (GT) extracts on cisplatin (cDDP)-induced nephrotoxicity in adult albino mice. Albino mice were randomly divided ...
2009 NOV 23 ... (6-OH-MLT) in NSCLC patients before and after treatment with standard chemotherapy ( cisplatin plus vinorelbine)." "The aim of this study was to investigate the ...
2009 NOV 23 ... this paper we analyzed the influence of two mechanistically diverse antitumor agents-cisplatin and methotrexate on the proliferation and cell cycle of two head and neck squamous ...
2009 NOV 17 ... hCtr1 is involved in the transport of platinum-based antitumor agents such as cisplatin (CDDP); however, the mechanisms that regulate hCtr1-mediated transport of these agents ...
2009 NOV 23 ... peritoneal, or fallopian tubal cancer who received IV docetaxel 60 to 70 mg/m(2) and IP cisplatin 80 to 85 mg/m(2) on day I and IP paclitaxel 60 to 70 Mg/m(2) on day 8 every 21 days were ...
2009 NOV 23 ... dose of 50.4-59.4 Gy), concurrent with two cycles of 5-fluorouracil (1000 mg/m(2)/d) and cisplatin (20 mg/m(2)/d), both given as 4-day continuous intravenous infusions during the first ...
2009 NOV 23 ... surfactants of different hydrocarbon chain lengths to allow loading of anticancer drug, cisplatin. The interfacial interactions and surfactant chain length effects on drug loading, ...
2009 NOV 16 ... resulted in significant epirubicin resistance and cross-resistance to 5-fluorouracil and cisplatin in various gastric cancer cell lines. GAS1 suppression promoted multidrug resistance ...
2009 NOV 17 ... MRI scanner. HER-2/neu-expressing NT cells were treated with Gd-DTPA-Gel-Cis (5 mc M cisplatin, 200 mg/mL Gel), Cis alone (5 mc M cisplatin), or Gel ...
2009 NOV 16 ... apoptotic cell death in high-grade tumor cells resistant to the chemotherapeutic drug cisplatin," wrote S.H. Dairkee and colleagues. The researchers concluded: "This is ...
2009 NOV 23 ... conducted a study "To define the effects of hepatic artery chemoembolization with cisplatin-lipiodol suspension and gelatin sponge particles on swine liver tissue and estimate the ...
2009 NOV 23 ... in cell death," investigators in Rome, Italy report. "In cell lines, upon cisplatin treatment, c-Abl phosphorylates TAp63 on specific tyrosine residues. Such modifications ...
2009 NOV 23 ... lymph node metastasis. The patient received targeted radiation therapy, combined with cisplatin. To date, 19 months after diagnosis, she is doing well without any evidence of disease. ...
2009 NOV 16 ... progesterone receptor membrane component 1 (PGRMC1) regulates the development and cisplatin (CDDP)-sensitivity of human ovarian tumors, PGRMC1 was depleted from a human ovarian ...
2009 NOV 23 ... A2 made cells susceptible to either serum withdrawal-induced cell cycle inhibition or cisplatin-induced apoptosis. Under apoptotic stimuli, annexin A2 was time-dependently cleaved. ...
2009 NOV 16 ... apoptosis and enhanced sensitivity to chemotherapeutic drugs, 5-fluorouracil, and cisplatin. In addition, Bay11-7082 and sulfasalazine suppressed the migration and invasive ...
